Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 3.

Journal Article

Pett, Sarah Lilian, Amin, Janaki ORCID: 0000-0003-2161-9366, Horban, Andrejz, Andrade-Villanueva, Jaime, Losso, Marcelo, Porteiro, Norma, Sierra Madero, Juan, Belloso, Waldo, Tu, Elise, Silk, David, Kelleher, Anthony ORCID: 0000-0002-0009-3337, Harrigan, Richard, Clark, Andrew, Sugiura, Wataru, Wolff, Marcelo ORCID: 0000-0002-9956-8872, Gill, John, Gatell, Jose, Fisher, Martin, Clarke, Amanda, Ruxrungtham, Kiat, Prazuck, Thierry, Kaiser, Rolf, Woolley, Ian, Alberto Arnaiz, Juan, Cooper, David, Rockstroh, Jurgen K., Mallon, Patrick and Emery, Sean ORCID: 0000-0001-6072-8309 (2016). Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study. Clin. Infect. Dis., 63 (1). S. 122 - 133. CARY: OXFORD UNIV PRESS INC. ISSN 1537-6591

Vieillard, Vincent, Combadiere, Behazine, Tubiana, Roland, Launay, Odile, Pialoux, Gilles, Cotte, Laurent, Girard, Pierre-Marie, Simon, Anne, Dudoit, Yasmine, Reynes, Jacques, Rockstroh, Juergen, Garcia, Felipe, Gatell, Jose, Devidas, Alain, Yazdanpanah, Yazdan, Weiss, Laurence, Faetkenheuer, Gerd, Autran, Brigitte, Joyeux, Delphine, Gharakhanian, Shahin, Debre, Patrice and Katlama, Christine (2019). HIV therapeutic vaccine enhances non-exhausted CD4(+) T cells in a randomised phase 2 trial. npj Vaccines, 4. LONDON: SPRINGERNATURE. ISSN 2059-0105

Vieillard, Vincent, Combadiere, Behazine, Tubiana, Roland, Pialoux, Gilles, Cotte, Laurent, Girard, Pierre Marie, Simon, Anne, Reynes, Jacques, Rockstroh, Juergen, Gatell, Jose, Devidas, Alain, Yazdanpanah, Yazdan, Launay, Odile, Weiss, Laurence, Autran, Brigitte, Gharakhanian, Shahin, Faetkenheuer, Gerd, Costagliola, Dominique, Debre, Patrice and Katlama, Christine (2018). A Novel Approach to Inhibit CD4 Exhaustion: Results of a Placebo-controlled Phase II Study of a gp41 Peptide Vaccine in HIV-1 Patients Under ART. Aids Res. Hum. Retrovir., 34. S. 49 - 50. NEW ROCHELLE: MARY ANN LIEBERT, INC. ISSN 1931-8405

This list was generated on Fri Mar 29 12:14:09 2024 CET.